7/14/18 Limitations of Time

We are all limited by time. As it slowly passes through the hourglass, we seem not to notice its steady, relentless flow. We start out with the hourglass full, but it drains into the lower basin, uncontrollable, irreclaimable, each grain a passing moment that can never be retrieved. When the glass is full, we are…

6/22/18 Deborah Robins – Home Fires

I am not a reviewer, nor a critic. I don’t like to criticize other’s work. It is often said about critics that they become critics because they cannot do. That leaves me right out of the critical realm, because I can and do. What I truly enjoy is the doings of others, especially when I…

6/22/18 Stillhouse Junkies – Over the Pass

I’ve known Stillhouse Junkie bassist Cody Tinnin for a long time, he and his whole extended family. Cody’s father, Glenn, and Uncle Bruce were high school friends and are still friends. My first official musical public performance experiences were as a duo with Bruce Tinnin, and later in bands together where we learned a lot…

6/22/18 Scott McQuaig – A Song Away from You

I am a fan of Scott McQuaig. His singing and songwriting are impeccable. He recently released a new CD called A SONG AWAY ROM YOU. He was kind enough to send me a copy in April since the USMail apparently mishandled my invitation to his CD release party. I just listened to it today. I…

5/25/18 Fame through Facebook Fakery

I’ve got lots of Facebook friends. The friend requests have been pouring in as of late to the count of dozens per day, nearly all of them fake as far as I can tell. The latest are multiple requests from CEOs of agencies, booking agents, A&R professionals, and a host of others all wanting to…

5/12/18 Summer’s Here

No. It’s not really summer, yet, but today sure seemed like it. Summers seem harsher here than they used to be. Maybe my tolerance is faltering. Lots of things at my age are faltering. I am glad to be still be here. We have been working long hours in Olive Branch, Mississippi, in the throes…

4/15/18 Two More Years

I have been on the Ruxolitinib trial for two years now. It has been good so far. The trial was designed to address the symptoms of CLL and prove, disprove, or measure its efficacy in individual patients. The requirements of the trial were that each person enrolled must not be treatment naive, meaning that they…